(Press-News.org) Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically significant increased risk, however a small increased risk could not be excluded, according to a study in the July 21 issue of JAMA. Additional analyses with another large group found that use of pioglitazone was associated with an increase in the risk of prostate and pancreatic cancer, although further investigation is needed to assess whether the associations are causal or due to other factors.
Assiamira Ferrara, M.D., Ph.D., of Kaiser Permanente Northern California, Oakland, and colleagues studied with several groups of persons with diabetes: a bladder cancer cohort that followed 193,099 persons (40 years or older in 1997-2002) until December 2012; 464 case patients and 464 matched controls were surveyed about additional confounders (factors that can influence outcomes that may improperly skew the results); and a cohort analysis of 10 additional cancers included 236,507 persons (40 years or older in 1997-2005) and followed until June 2012. The additional cancers were prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma, pancreas, kidney/renal pelvis, rectum, and melanoma. All cohorts were from Kaiser Permanente Northern California.
Among the persons in the bladder cancer cohort, 34,181 (18 percent) received pioglitazone (median duration, 2.8 years) and 1,261 had incident bladder cancer. Ever use of pioglitazone was not associated with bladder cancer risk. Results were similar in case-control analyses (pioglitazone use: 19.6 percent among case patients and 17.5 percent among controls).
In adjusted analyses, there was no association with 8 of the 10 additional cancers; ever use of pioglitazone was associated with increased risk of prostate cancer and pancreatic cancer. No clear patterns of risk for any cancer were observed for time since initiation, duration, or dose.
"These studies were conducted to address safety concerns related to the risk of cancer after treatment with pioglitazone," the authors write.
"There was no statistically significant increased risk of bladder cancer associated with pioglitazone use. However, a small increased risk, as previously observed, could not be excluded. The increased prostate and pancreatic cancer risks associated with ever use of pioglitazone merit further investigation to assess whether the observed associations are causal or due to chance, residual confounding, or reverse causality."
(doi:10.1001/jama.2015.7996; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: The study was funded by a grant from Takeda Development Center Americas Inc. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
Editorial: The Safety of Prescription Drugs
Joshua M. Sharfstein, M.D., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and Aaron S. Kesselheim, M.D., J.D., M.P.H., of Brigham and Women's Hospital, Boston, comment on the findings of this study in an accompanying editorial.
"That these data from the report by Lewis et al shed new light on the safety of pioglitazone reflects the dynamic nature of many drug safety questions. As in this case, caution and further review are the appropriate responses to many safety signals. But when emerging available data--clinical, laboratory, observational, and even population-based studies-- create a compelling picture of risk in excess of potential benefit to patients, the FDA should act to protect the public."
(doi:10.1001/jama.2015.7151; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
Editorial: Evaluating Research on the Safety of Medical Therapies
In an accompanying editorial, Phil B. Fontanarosa, M.D., M.B.A., Executive Deputy Editor, JAMA, Chicago, and colleagues discuss the responsibility of medical journals to the health of the public in reviewing studies evaluating the potential relationship between drugs, devices, or vaccines and adverse outcomes.
"The findings of the study by Lewis et al demonstrating no statistically significant association between the use of pioglitazone and the risk of bladder cancer are important because of the prevalence of type 2 diabetes, fairly widespread use of pioglitazone, and safety concerns about this drug."
"Even though no observational study examining the relationship between an exposure and an outcome can definitively establish 'positive' cause-and-effect results, and no observational study can definitively prove 'negative' results, each study adds to the totality of evidence regarding the safety of drugs, devices, and vaccines. By publishing the results of these studies, JAMA will continue to provide information physicians can use in discussions with patients and regulatory bodies can use in policy decisions about the benefits and risks of various therapies."
(doi:10.1001/jama.2015.8232; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
INFORMATION:
In a phase 2 trial that included nearly 1,000 adults, the AS03 and MF59 adjuvants (a component that improves immune response of inactivated influenza vaccines) increased the immune responses to two doses of an inactivated H7N9 influenza vaccine, with AS03-adjuvanted formulations inducing the highest amount of antibody response, according to a study in the July 21 issue of JAMA.
In March 2013 the first human infections with the avian influenza A(H7N9) virus were reported in China, and since that time hundreds of cases have been documented. While most infections are believed ...
Researchers have found an association between treatment with the antibiotic dicloxacillin and a decrease in international normalized ratio (INR; a measure of blood coagulation) levels among patients taking the vitamin K antagonists warfarin or phenprocoumon, according to a study in the July 21 issue of JAMA.
A challenge in the use of vitamin K antagonists (VKAs) is the potential for drug-drug interactions, resulting in insufficient or excessive anticoagulation. Solid data are lacking for most alleged interactions. In case reports, the commonly used antibiotic dicloxacillin ...
WASHINGTON, DC, July 21, 2015 - It's not unusual for two drivers to depart from the same location, head out to the same destination, drive more or less the same speed and nevertheless arrive at dramatically different times, with one driver taking significantly longer to arrive. While this can simply be bad luck, sometimes the reason isn't an obvious external event.
And if you are a world traveler, you've likely noticed the fact that transportation works like a charm in some countries, in the sense that you can plan your commute or trip via public bus with confidence. ...
The negative health effects of international air travel are well documented but now it seems that the common elderberry can provide some relief.
Associate Professor Evelin Tiralongo and Dr Shirley Wee from Griffith's Menzies Health Institute Queensland (MHIQ) have completed a clinical trial showing that an elderberry supplement can provide some protection from cold and flu-like symptoms following long-haul flights.
Intercontinental air travel can be stressful and affect a passenger's physical and psychological wellbeing. Whilst jet lag and fatigue remain the best known ...
WASHINGTON --Tamsulosin works no better than placebo on small kidney stones, but does improve passage of more large kidney stones than placebo does. The results of this large clinical trial evaluating tamsulosin versus placebo were published online Friday in Annals of Emergency Medicine ("Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Trial (The DUST Trial)").
"Kidney stones bring more than a million Americans a year to emergency departments because they are excruciatingly painful," said lead study author Jeremy Furyk, ...
COLUMBUS, Ohio--Gravity data captured by satellite has allowed researchers to take a closer look at the geology deep beneath the Tibetan Plateau.
The analysis, published in the journal Nature Scientific Reports, offers some of the clearest views ever obtained of rock moving up to 50 miles below the plateau, in the lowest layer of Earth's crust.
There, the Indian tectonic plate presses continually northward into the Eurasian tectonic plate, giving rise to the highest mountains on Earth--and deadly earthquakes, such as the one that killed more than 9,000 people in Nepal ...
CHAMPAIGN, Ill. -- A microbe found in caves produces a compound that inhibits Pseudogymnoascus destructans, the fungus that causes white-nose syndrome in bats, researchers report in the journal Mycopathologia. The finding could lead to treatments that kill the fungus while minimizing disruption to cave ecosystems, the researchers say.
The yeast Candida albicans produces the compound: trans, trans-farnesol.
Candida species are already present in caves where bats hibernate and have been isolated from the bodies of healthy, hibernating bats, said University of Illinois ...
A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection--an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept and reliably adhere to daily PrEP dosing. Men who have sex with men (MSM) and transgender women (TGW) in New York and Thailand also successfully adhered to daily dosing.
PrEP--which consists of a daily dose of two antiretrovirals, ...
Dr. Michele Rodda describes two new tropical plants species from the Hoya genus, found on the world's third largest island Borneo. The genus is one of the largest and most complex plant groups in Asia. The first to be described in the paper, H. ruthiae, is characterised with its lack of coloured milk-like sap typical for most of the Hoya species, and H. bakoensis - with its strict preference for growing epiphytically (without causing any harm to its host) and rooting inside ant nests. The study is published in the open-access journal PhytoKeys.
Collected by Ruth Kiew ...
URBANA, Ill. - Controlled burning is widely used to maintain biodiversity and enhance regeneration of important deciduous tree species such as oak and hickory, but a recent University of Illinois study found that this practice also increases the growth of an aggressive species of invasive grass.
Microstegium vimineum (also called Japanese stiltgrass or Nepalese browntop) is an abundant non-native grass in southern Illinois where the study was conducted.
"We found that fire promotes the recruitment and growth of M. vimineum, particularly under moist soil conditions," ...
